In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: Are they laboratory artefacts?

Author： Grignani Claudio Noris Patrizia Tinelli Carmine Barosi Giovanni Balduini Carlo

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.20, Iss.2, 2009-03, pp. : 131-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased leukocyte–platelet adhesion in chronic myeloproliferative disorders with high platelet counts

By Kaplar M. Kappelmayer J. Kiss A. Szabo K. Udvardy M.

Platelets, Vol. 11, Iss. 3, 2000-05 ,pp. : 183-184

Informa Healthcare

Access to resources Recommend Favorite

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

By Villmow T. Kemkes-Matthes B. Matzdorff A.C.

Thrombosis Research, Vol. 108, Iss. 2, 2002-11 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

In vivo effect of losartan on platelet aggregation in patients with hypertension

By Akdemir Ramazan Özhan Hakan Yazici Mehmet Gunduz Huseyin Duran Sadık Gurel Cigdem Ozdas Sule Uyan Cihangir Basar Isık Ulutin Turgut

Heart and Vessels, Vol. 19, Iss. 4, 2004-07 ,pp. : 167-171

Springer Publishing Company

Access to resources Recommend Favorite

Effect of ciprofibrate on platelet aggregation in patients with combined hyperlipidemia

By Viigimaa R. Valkman A. Kask T. Joudu M.

Platelets, Vol. 9, Iss. 3-4, 1998-07 ,pp. : 265-267

Informa Healthcare

Access to resources Recommend Favorite

PHOSPHODIESTERASE INHIBITORS PIROXIMONE AND ENOXIMONE INHIBIT PLATELET AGGREGATION IN VIVO AND IN VITRO

By Buerke M. Cyrus T. Darius H.

Thrombosis Research, Vol. 88, Iss. 2, 1997-10 ,pp. : 89-98

Elsevier

Access to resources Recommend Favorite